| Literature DB >> 20044576 |
Takako Yoshida-Moriguchi1, Liping Yu, Stephanie H Stalnaker, Sarah Davis, Stefan Kunz, Michael Madson, Michael B A Oldstone, Harry Schachter, Lance Wells, Kevin P Campbell.
Abstract
Alpha-dystroglycan (alpha-DG) is a cell-surface glycoprotein that acts as a receptor for both extracellular matrix proteins containing laminin-G domains and certain arenaviruses. Receptor binding is thought to be mediated by a posttranslational modification, and defective binding with laminin underlies a subclass of congenital muscular dystrophy. Using mass spectrometry- and nuclear magnetic resonance (NMR)-based structural analyses, we identified a phosphorylated O-mannosyl glycan on the mucin-like domain of recombinant alpha-DG, which was required for laminin binding. We demonstrated that patients with muscle-eye-brain disease and Fukuyama congenital muscular dystrophy, as well as mice with myodystrophy, commonly have defects in a postphosphoryl modification of this phosphorylated O-linked mannose, and that this modification is mediated by the like-acetylglucosaminyltransferase (LARGE) protein. These findings expand our understanding of the mechanisms that underlie congenital muscular dystrophy.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20044576 PMCID: PMC2978000 DOI: 10.1126/science.1180512
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728